These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3745 related articles for article (PubMed ID: 16990136)
21. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Brüstle A; Heink S; Huber M; Rosenplänter C; Stadelmann C; Yu P; Arpaia E; Mak TW; Kamradt T; Lohoff M Nat Immunol; 2007 Sep; 8(9):958-66. PubMed ID: 17676043 [TBL] [Abstract][Full Text] [Related]
22. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis. Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264 [TBL] [Abstract][Full Text] [Related]
23. Regulation of gut inflammation and th17 cell response by interleukin-21. Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085 [TBL] [Abstract][Full Text] [Related]
24. Restricted microbiota and absence of cognate TCR antigen leads to an unbalanced generation of Th17 cells. Lochner M; Bérard M; Sawa S; Hauer S; Gaboriau-Routhiau V; Fernandez TD; Snel J; Bousso P; Cerf-Bensussan N; Eberl G J Immunol; 2011 Feb; 186(3):1531-7. PubMed ID: 21178008 [TBL] [Abstract][Full Text] [Related]
25. Novel therapeutic targets along the Th17 pathway. Ouyang W; Filvaroff E; Hu Y; Grogan J Eur J Immunol; 2009 Mar; 39(3):670-5. PubMed ID: 19283720 [TBL] [Abstract][Full Text] [Related]
26. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. Hirota K; Hashimoto M; Yoshitomi H; Tanaka S; Nomura T; Yamaguchi T; Iwakura Y; Sakaguchi N; Sakaguchi S J Exp Med; 2007 Jan; 204(1):41-7. PubMed ID: 17227914 [TBL] [Abstract][Full Text] [Related]
27. G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo. Toh HC; Sun L; Soe Y; Wu Y; Phoon YP; Chia WK; Wu J; Wong KY; Tan P Clin Immunol; 2009 Jul; 132(1):83-92. PubMed ID: 19345152 [TBL] [Abstract][Full Text] [Related]
28. Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells. Sujino T; Kanai T; Ono Y; Mikami Y; Hayashi A; Doi T; Matsuoka K; Hisamatsu T; Takaishi H; Ogata H; Yoshimura A; Littman DR; Hibi T Gastroenterology; 2011 Sep; 141(3):1014-23. PubMed ID: 21699791 [TBL] [Abstract][Full Text] [Related]
29. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560 [TBL] [Abstract][Full Text] [Related]
30. RORC2: the master of human Th17 cell programming. Unutmaz D Eur J Immunol; 2009 Jun; 39(6):1452-5. PubMed ID: 19499530 [TBL] [Abstract][Full Text] [Related]
31. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation. Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181 [TBL] [Abstract][Full Text] [Related]
32. Rapid ex vivo isolation and long-term culture of human Th17 cells. Streeck H; Cohen KW; Jolin JS; Brockman MA; Meier A; Power KA; Waring MT; Alter G; Altfeld M J Immunol Methods; 2008 Apr; 333(1-2):115-25. PubMed ID: 18314131 [TBL] [Abstract][Full Text] [Related]
33. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis. Shi Y; Wang H; Su Z; Chen J; Xue Y; Wang S; Xue Y; He Z; Yang H; Zhou C; Kong F; Liu Y; Yang P; Lu L; Shao Q; Huang X; Xu H Scand J Immunol; 2010 Sep; 72(3):250-5. PubMed ID: 20696023 [TBL] [Abstract][Full Text] [Related]
37. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP Immunity; 2008 Dec; 29(6):958-70. PubMed ID: 19084435 [TBL] [Abstract][Full Text] [Related]
38. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease. Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533 [TBL] [Abstract][Full Text] [Related]
39. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. Fantini MC; Rizzo A; Fina D; Caruso R; Becker C; Neurath MF; Macdonald TT; Pallone F; Monteleone G Eur J Immunol; 2007 Nov; 37(11):3155-63. PubMed ID: 17918200 [TBL] [Abstract][Full Text] [Related]
40. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. Annunziato F; Cosmi L; Liotta F; Maggi E; Romagnani S Int Immunol; 2008 Nov; 20(11):1361-8. PubMed ID: 18820263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]